Public unlisted company Ecobiotics subsidiary Qbiotics will put its lead compound EBC-46 into human phase 1 trials in Aus/Sep this year. It'll be the first drug from Australia's tropical rainforest to go into human trials. If it works as well as it has in the animal trials it has the potential to be huge.
